Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges (Q28287345)

Living beyond our physiological means: small vessel disease of the brain is an expression of a systemic failure in arteriolar function: a unifying hypothesis

Europe PubMed Central

title

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges (English)

0 references

1 reference

Leonardo Pantoni

1

0 references

language of work or name

English

0 references

publication date

July 2010

0 references

published in

Lancet Neurology

0 references

volume

9

0 references

page(s)

689-701

0 references

issue

7

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Postmortem examination of vascular lesions in cognitive impairment: a survey among neuropathological services.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Periventricular venous collagenosis: association with leukoaraiosis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

CIRCULATIONS OF THE CEREBRAL HEMISPHERES.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Centrifugal elements in the vascular pattern of the deep intracerebral blood supply.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

The Human Periventricular Arterial Blood Supply and the Anatomy of Cerebral Infarctions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Pathogenesis of leukoaraiosis: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Association of HTRA1 mutations and familial ischemic cerebral small-vessel disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Genetics of ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Monogenic vessel diseases related to ischemic stroke: a clinical approach

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Single gene disorders causing ischaemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Small-vessel vasculitis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Central nervous system injury by therapeutic irradiation.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Microvascular injury and blood-brain barrier leakage in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Medullary arteries in aging and dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Nonhypertensive cerebral small-vessel disease. An autopsy study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cerebral amyloid angiopathy. A critical review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cerebral amyloid angiopathy without and with cerebral hemorrhages: a comparative histological study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Incidence of cerebrovascular lesions in Alzheimer's disease: a postmortem study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Severe cerebral amyloid angiopathy characterizes an underestimated variant of vascular dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cerebral amyloid angiopathy and thrombolysis-related intracerebral haemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cerebral amyloid angiopathy and lobar intracerebral hemorrhage.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cerebral microbleeds on MRI: prevalence, associations, and potential clinical implications

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cerebral microhemorrhage

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Leukoencephalopathy in diffuse hemorrhagic cerebral amyloid angiopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Leukoencephalopathy with cerebral amyloid angiopathy: a semiquantitative and morphometric study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Silent ischemic infarcts are associated with hemorrhage burden in cerebral amyloid angiopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Do in vivo experimental models reflect human cerebral small vessel disease? A systematic review.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Microbleeds versus macrobleeds: evidence for distinct entities

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Pathophysiology of age-related cerebral white matter changes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cerebral white matter is highly vulnerable to ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Selective glial vulnerability following transient global ischemia in rat brain.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Incomplete infarct and delayed neuronal death after transient middle cerebral artery occlusion in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

LACUNES: SMALL, DEEP CEREBRAL INFARCTS.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Lacunar strokes and infarcts: a review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

The fallacy of the lacune hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Lacunar infarcts. Pathogenesis and validity of the clinical syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Is breakdown of the blood-brain barrier responsible for lacunar stroke, leukoaraiosis, and dementia?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cyclooxygenase-2 is induced in microglia during chronic cerebral ischemia in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Inflammation and white matter damage in vascular cognitive impairment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Microglial activation in white matter lesions and nonlesional white matter of ageing brains

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cerebral microbleeds: a guide to detection and interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

1 reference

7 January 2021

Pontine ischemic rarefaction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

T2-weighted hyperintense MRI lesions in the pons in patients with atherosclerosis. Amsterdam Vascular Medicine Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

The relation between white-matter lesions and cognition

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

MRI findings of small subcortical "lacunar-like" infarction resulting from large vessel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

What causes lacunar stroke?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Two types of lacunar infarcts: further arguments from a study on prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Distinguishing silent lacunar infarction from enlarged Virchow-Robin spaces: a magnetic resonance imaging and pathological study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Infraputaminal 'lacunes'. Clinical and pathological correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Virchow-Robin spaces relate to cerebral small vessel disease severity

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Long-term prognosis after lacunar infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Confusion and memory loss from capsular genu infarction: a thalamocortical disconnection syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Leukoaraiosis in relation to prognosis for patients with lacunar infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Functional outcome in patients with lacunar infarction.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Twenty-four-hour blood pressure and MRI as predictive factors for different outcomes in patients with lacunar infarct.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cognitive consequences of multiple lacunes and leukoaraiosis as vascular cognitive impairment in community-dwelling elderly individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Location of lacunar infarcts correlates with cognition in a sample of non-disabled subjects with age-related white-matter changes: the LADIS study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Silent brain infarcts and the risk of dementia and cognitive decline.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Silent brain infarcts: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Not-so-silent infarcts.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

World Stroke Day 2008: "little strokes, big trouble".

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Prevalence of CT-detected cerebral abnormalities in an elderly Swedish population sample.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Lacunar infarcts defined by magnetic resonance imaging of 3660 elderly people: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Prevalence and correlates of silent cerebral infarcts in the Framingham offspring study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Annual Incidence of First Silent Stroke in the United States: A Preliminary Estimate

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Are white matter lesions directly associated with cognitive impairment in patients with lacunar infarcts?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Leukoaraiosis: from an ancient term to an actual marker of poor prognosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

The significance of cerebral white matter abnormalities 100 years after Binswanger's report. A review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

The effect of white matter lesions on cognition in the elderly--small but detectable

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

White matter hyperintensities as a predictor of neuropsychological deficits post-stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cerebral white matter lesions and the risk of dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Longitudinal cognitive decline in subcortical ischemic vascular disease--the LADIS Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Progression of leukoaraiosis and cognition

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Age, neuropathology, and dementia.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Brain microbleeds and global cognitive function in adults without neurological disorder

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Vascular cognitive impairment.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Subcortical ischaemic vascular dementia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Subcortical vascular dementia as a specific target for clinical trials

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cognitive decline and dementia related to cerebrovascular diseases: some evidence and concepts

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

White matter abnormalities in mobility-impaired older persons

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

A longitudinal study of gait and balance dysfunction in normal older people.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Association of gait and balance disorders with age-related white matter changes: The LADIS Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

A magnetic resonance imaging study of white matter lesions in depression and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Severe deep white matter lesions and outcome in elderly patients with major depressive disorder: follow up study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Urinary complaints in nondisabled elderly people with age-related white matter changes: the Leukoaraiosis And DISability (LADIS) Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Impact of age-related cerebral white matter changes on the transition to disability -- the LADIS study: rationale, design and methodology.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Risk of rapid global functional decline in elderly patients with severe cerebral age-related white matter changes: the LADIS study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Changes in white matter as determinant of global functional decline in older independent outpatients: three year follow-up of LADIS (leukoaraiosis and disability) study cohort

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

The natural history of lacunar infarction: the Oxfordshire Community Stroke Project

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Epidemiological characteristics of lacunar infarcts in a population

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Epidemiology of ischemic stroke subtypes according to TOAST criteria: incidence, recurrence, and long-term survival in ischemic stroke subtypes: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Lacunar infarcts: no black holes in the brain are benign.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Does thrombolysis benefit patients with lacunar syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the A

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Leukoaraiosis Is a Risk Factor for Symptomatic Intracerebral Hemorrhage After Thrombolysis for Acute Stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Leukoaraiosis and intracerebral hemorrhage after thrombolysis in acute stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Prognostic importance of leukoaraiosis in patients with symptomatic internal carotid artery stenosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Chronic ischemic cerebral white matter disease is a risk factor for nonfocal neurologic injury after total aortic arch replacement

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Supratentorial age-related white matter changes predict outcome in cerebellar stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

White matter lesions in the elderly: pathophysiological hypothesis on the effect on brain plasticity and reserve

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Small vessels, big problems.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

The Canadian American Ticlopidine Study (CATS) in thromboembolic stroke

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cilostazol stroke prevention study: A placebo-controlled double-blind trial for secondary prevention of cerebral infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Results of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial by stroke subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Reliability and validity of blood pressure measurement in the Secondary Prevention of Small Subcortical Strokes study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

A double-blind, placebo-controlled multicentre study of memantine in mild to moderate vascular dementia (MMM500).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Galantamine treatment of vascular dementia: a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

A preliminary open trial with nimodipine in patients with cognitive impairment and leukoaraiosis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Efficacy and safety of nimodipine in subcortical vascular dementia: a subgroup analysis of the Scandinavian Multi-Infarct Dementia Trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Efficacy and safety of nimodipine in subcortical vascular dementia: a randomized placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Donepezil in patients with subcortical vascular cognitive impairment: a randomised double-blind trial in CADASIL.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

MRI-defined subcortical ischemic vascular disease: baseline clinical and neuropsychological findings. The LADIS Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Comparison of the Alzheimer's Disease Assessment Scale Cognitive Subscale and the Vascular Dementia Assessment Scale in differentiating elderly individuals with different degrees of white matter changes. The LADIS Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Rivastigmine in subcortical vascular dementia: an open 22-month study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Rivastigmine in subcortical vascular dementia: A randomized, controlled, open 12-month study in 208 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Efficacy, safety and tolerability of rivastigmine capsules in patients with probable vascular dementia: the VantagE study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

White matter lesion progression: a surrogate endpoint for trials in cerebral small-vessel disease

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Effects of blood pressure lowering on cerebral white matter hyperintensities in patients with stroke: the PROGRESS (Perindopril Protection Against Recurrent Stroke Study) Magnetic Resonance Imaging Substudy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Effect of pravastatin on cerebral infarcts and white matter lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Effects of statins on the progression of cerebral white matter lesion: Post hoc analysis of the ROCAS (Regression of Cerebral Artery Stenosis) study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cognitive impairment and white matter damage in hypertension: a pilot study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Progression of cerebral white matter lesions: 6-year results of the Austrian Stroke Prevention Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Incidence, manifestations, and predictors of worsening white matter on serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Progression of white matter hyperintensities in elderly individuals over 3 years

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Periventricular white matter lucencies relate to low vitamin B12 levels in patients with small vessel stroke.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Cerebrospinal fluid biomarkers of white matter lesions - cross-sectional results from the LADIS study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

Neurofilament protein in cerebrospinal fluid: a marker of white matter changes.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

The cognitive correlates of white matter abnormalities in normal aging: a quantitative review

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2810%2970104-6

7 January 2021

10.1016/S1474-4422(10)70104-6

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

348786

348786

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference